» Articles » PMID: 3093524

Variation and Adaptation of Pseudomonas Aeruginosa Toxicity to HeLa Cells and Fibroblasts

Overview
Specialty Microbiology
Date 1986 Sep 1
PMID 3093524
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The toxic components of supernatants from Pseudomonas aeruginosa cultures directed against HeLa cells and Staphylococcus aureus were evaluated with the aim of discovering interactions. Supernatants of eight different strains of P. aeruginosa were assayed for cytotoxic activity. All were active against HeLa cells; seven were toxic for S. aureus. On repeated suspension of P. aeruginosa in 0.9% sodium chloride solution, a shift from HeLa cell toxicity to staphylococcal lytic activity occurred along with a change of toxic activity from a high (50,000 +/- 5,000) to a low (8,000 +/- 400) molecular weight (MW) range on gel filtration. Addition of protein to the minimal medium of cultures producing material toxic only for S. aureus reactivated the generation of HeLa cell-toxic material. Cultivation of P. aeruginosa in the presence of HeLa cells and a chloramphenicol supplement produced suppression of the generation of material toxic for S. aureus but facilitated that of HeLa-toxic material of high MW. Adaptation of toxicity against fibroblasts developed only on cocultivation of P. aeruginosa together with S. aureus and in the presence of fibroblasts. Under these conditions a strong lytic activity for S. aureus appeared, even in the presence of chloramphenicol. Chloramphenicol caused the material toxic for fibroblasts to elute at a low MW well separated from that toxic for HeLa cells. In contrast to the high-MW toxic substances, the low-MW material did not induce antibodies after injection into rabbits. This may explain failures of vaccination against P. aeruginosa infection and of serum therapy of homologous sepsis in humans.

Citing Articles

In situ survival of plasmid-bearing and plasmidless Pseudomonas aeruginosa in pristine tropical waters.

Toranzos G, Ahearn D, Hazen T Appl Environ Microbiol. 1988; 54(10):2574-7.

PMID: 3144245 PMC: 204319. DOI: 10.1128/aem.54.10.2574-2577.1988.


Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.

Hollsing A, Granstrom M, Vasil M, Wretlind B, Strandvik B J Clin Microbiol. 1987; 25(10):1868-74.

PMID: 3117842 PMC: 269358. DOI: 10.1128/jcm.25.10.1868-1874.1987.

References
1.
PAVLOVSKIS O, Edman D, Leppla S, Wretlind B, Lewis L, Martin K . Protection against experimental Pseudomonas aeruginosa infection in mice by active immunization with exotoxin A toxoids. Infect Immun. 1981; 32(2):681-9. PMC: 351501. DOI: 10.1128/iai.32.2.681-689.1981. View

2.
Keilich G, BROSSMER R, Ehrhardt T, PECH H, Muller H, Sonntag H . [Exotoxins of Pseudomonas aeruginosa. I. Communication: isolation, purification and biochemical analysis]. Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol. 1982; 252(1):57-73. View

3.
LIU P . Exotoxins of Pseudomonas aeruginosa. I. Factors that influence the production of exotoxin A. J Infect Dis. 1973; 128(4):506-13. DOI: 10.1093/infdis/128.4.506. View

4.
Lory S, Tai P, Davis B . Mechanism of protein excretion by gram-negative bacteria: Pseudomonas aeruginosa exotoxin A. J Bacteriol. 1983; 156(2):695-702. PMC: 217885. DOI: 10.1128/jb.156.2.695-702.1983. View

5.
Shimizu S, Tani Y, Yamada H, Tabata M, Murachi T . Enzymatic determination of serum-free fatty acids: a colorimetric method. Anal Biochem. 1980; 107(1):193-8. DOI: 10.1016/0003-2697(80)90511-4. View